| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |